WEDGE CAPITAL MANAGEMENT L L P/NC

Position in SVRA — Savara Inc

CIK 1015308 CHARLOTTE, NC

Position in SVRA

as of Mar 31, 2026 · filed Apr 13, 2026 Compact

Position Value

$1,681,669

New position

Shares Held

307,998

first reported quarter

Ownership

0.150%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#58

of 184 holders

Holding Since

Mar 2026

1 quarter on record

Voting authority Sole 79.11577347904857.ToString("F0")% Shared 0.ToString("F0")% None 20.884226520951437.ToString("F0")%

Healthcare · as of Mar 31, 2026

WEDGE CAPITAL MANAGEMENT L L P/NC holds $111,356,380 across 7 Biotechnology names. SVRA ranks #6 (1.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RPRX	Royalty Pharma plc	890,840	$42,733,594
2	REGN	Regeneron Pharmaceuticals, Inc.	39,712	$30,683,079
3	JAZZ	Jazz Pharmaceuticals plc	160,006	$30,249,134
4	HRMY	Harmony Biosciences Holdings, Inc.	88,999	$2,492,861
5	RYTM	Rhythm Pharmaceuticals, Inc.	24,535	$2,133,808
6	SVRA	Savara Inc This page	307,998	$1,681,669
7	TARS	Tarsus Pharmaceuticals, Inc.	19,704	$1,382,235

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,681,669	307,998	—	Shares	Sole	2026-04-13
No filing history on record for this holder in this stock.